VC Funding: Increasing Prior Rounds; New Strategy In Lieu Of An IPO?

Many biotechnology companies raised new venture capital in 2015 within months of registering with the US Securities and Exchange Commission (SEC) to launch an initial public offering, but the trend seems to have reversed course in 2016.